Edition:
United States

Insider Trading: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

389.50USD
18 Aug 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$389.50
Open
--
Day's High
--
Day's Low
--
Volume
4
Avg. Vol
1,394
52-wk High
$400.00
52-wk Low
$292.00

NAWANA NAMAL

Institutional Holders

% Shares Owned: 57.17%
# of Holders: 34
Total Shares Held: 1,014,140
3 Mo. Net Change: -576,146
# New Positions: 13
# Closed Positions: 6
# Increased Positions: 18
# Reduced Positions: 13
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

Gregg Powers

54 2014 Independent Chairman of the Board

Namal Nawana

46 2014 President, Chief Executive Officer, Director

James Hinrichs

49 2015 Chief Financial Officer, Executive Vice President

Daniella Cramp

43 2014 Global President - Cardiometabolic Business Unit

Sanjay Malkani

47 2013 Global President - Toxicology

Avi Pelossof

54 2013 Global President - Infectious Disease Business Unit

Ellen Chiniara

58 2014 Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, Secretary

Robert Hargadon

60 2014 Senior Vice President - Global Human Resources

John Bridgen

70 2010 Senior Vice President - Business Development

Mark Gladwell

42 2015 Senior Vice President - Global Operations

Melissa Guerdan

43 2014 Senior Vice President - Global Quality and Regulatory Assurance

Renuka Uppaluri

46 2015 Senior Vice President - Global Research and Development

Jonathan Wygant

46 2016 Chief Accounting Officer, Vice President - Finance, Controller

Geoffrey Ginsburg

60 2015 Independent Director

Carol Goldberg

86 2001 Independent Director

John Levy

61 2001 Independent Director

Brian Markison

57 2013 Independent Director

Thomas McKillop

74 2013 Independent Director

John Quelch

65 2003 Independent Director

James Roosevelt

71 2009 Independent Director

Juliet Cunningham

2015 Vice President - Alere Investor Relations